Molina Healthcare, Inc (NYSE:MOH) Receives Average Rating of “Hold” from Brokerages

Shares of Molina Healthcare, Inc (NYSE:MOH) have been assigned a consensus rating of “Hold” from the thirteen ratings firms that are covering the firm, Marketbeat Ratings reports. Two analysts have rated the stock with a sell recommendation, nine have given a hold recommendation and two have given a buy recommendation to the company. The average 1-year price target among brokers that have issued a report on the stock in the last year is $169.2143.

A number of research firms recently commented on MOH. Deutsche Bank Aktiengesellschaft set a $310.00 price objective on Molina Healthcare in a report on Friday, March 13th. Weiss Ratings reiterated a “sell (d+)” rating on shares of Molina Healthcare in a report on Thursday, January 22nd. Truist Financial dropped their price objective on Molina Healthcare from $190.00 to $145.00 and set a “hold” rating for the company in a report on Tuesday, February 17th. Cantor Fitzgerald dropped their price objective on Molina Healthcare from $180.00 to $144.00 and set a “neutral” rating for the company in a report on Monday, February 9th. Finally, UBS Group set a $173.00 price objective on Molina Healthcare in a report on Friday, March 13th.

Institutional Investors Weigh In On Molina Healthcare

Several large investors have recently modified their holdings of MOH. AQR Capital Management LLC increased its holdings in shares of Molina Healthcare by 217.0% in the third quarter. AQR Capital Management LLC now owns 2,934,130 shares of the company’s stock worth $561,475,000 after acquiring an additional 2,008,458 shares in the last quarter. 8 Knots Management LLC bought a new stake in shares of Molina Healthcare in the fourth quarter worth about $198,942,000. Victory Capital Management Inc. increased its holdings in shares of Molina Healthcare by 344.3% in the third quarter. Victory Capital Management Inc. now owns 963,526 shares of the company’s stock worth $184,380,000 after acquiring an additional 746,639 shares in the last quarter. Madison Avenue Partners LP bought a new stake in shares of Molina Healthcare in the fourth quarter worth about $110,003,000. Finally, Norges Bank bought a new stake in shares of Molina Healthcare in the fourth quarter worth about $109,766,000. 98.50% of the stock is currently owned by institutional investors.

Molina Healthcare Trading Down 1.6%

NYSE MOH opened at $147.53 on Wednesday. The stock has a 50-day simple moving average of $143.41 and a 200 day simple moving average of $161.00. The company has a market capitalization of $7.68 billion, a PE ratio of 17.23 and a beta of 0.55. The company has a current ratio of 1.69, a quick ratio of 1.69 and a debt-to-equity ratio of 0.97. Molina Healthcare has a 12 month low of $121.06 and a 12 month high of $347.79.

Molina Healthcare (NYSE:MOH) last released its quarterly earnings data on Thursday, February 5th. The company reported ($2.75) EPS for the quarter, missing analysts’ consensus estimates of $0.43 by ($3.18). The company had revenue of $11.38 billion during the quarter, compared to the consensus estimate of $10.90 billion. Molina Healthcare had a net margin of 1.04% and a return on equity of 13.60%. The company’s revenue for the quarter was up 8.3% compared to the same quarter last year. During the same quarter in the prior year, the company posted $5.05 EPS. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. Research analysts forecast that Molina Healthcare will post 24.4 EPS for the current year.

Molina Healthcare Company Profile

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.